Abstract
BackgroundMTX and bDMARDs are the core treatments of chronic inflammatory arthritis (IA). We lack information on the patients' problems and needs in daily life, particularly on safety issues.Objectives1-collect the most...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
